BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  ResMed Adds Remote Patient Monitoring to AirMini, World’s Smallest CPAP

  ResMed today announced that AirMini, the world’s smallest PAP device, is now connected to AirView, the world’s largest remote patient monitoring platform.

  November 6, 2017

   · 

  2 min read
• BioMidwest

  Exicure Closes Additional $11.2 Million in Private Financing to Advance Its Gene Regulatory and Immunotherapeutic Programs

  Exicure today announced the closing of approximately $11.2 million in subsequent financing led by Luye Pharma Group and others including Eager Info Investments LTD, Knoll Capital Management and Purple Arch Ventures.

  November 6, 2017

   · 

  4 min read
• Business

  CytRx Announces Strategic Realignment of Clinical Development Team

  Going forward, CytRx’s drug development, manufacturing and regulatory activities will be led by Hurley Consulting Associates Ltd.

  November 6, 2017

   · 

  3 min read
• Drug Development

  Concert Pharmaceuticals Announces Completion of Enrollment in First Cohort of CTP-543 Phase IIa Trial

  The Phase 2a trial is expected to be completed in the second half of 2018.

  November 6, 2017

   · 

  5 min read
• Business

  Atonarp and IMA Life Enter Supply Agreement For Pharmaceutical Lyophilization Applications

  The AMS solution was developed in collaboration between IMA Life, Atonarp and a major pharma company with purpose-built quantitative instrumentation for the application of freeze-drying and aseptic processing.

  November 6, 2017

   · 

  3 min read
• Policy

  Collegium Notified that the FDA Will Not Meet PDUFA Goal Date for sNDA for Xtampza ER

  Collegium CEO says the FDA hasn’t requested any additional scientific information or data.

  November 6, 2017

   · 

  8 min read
• Bio NC

  Panaceutics to Participate in Personalized Medicine Conference at Harvard Medical School - November 14-16th

  Panaceutics today announced that it has joined the Personalized Medicine Coalition and has been invited to participate in the 13th Annual Personalized Medicine Conference on November 14th through 16th, hosted by Harvard Medical School in Boston, MA.

  November 6, 2017

   · 

  2 min read
• Pharm Country

  ContraVir Pharmaceuticals to Receive Non-Dilutive Funding through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

  As a result, the company expects to receive approximately $1.6 million of net cash proceeds prior to the end of 2017.

  November 6, 2017

   · 

  3 min read
• Drug Development

  Novartis Seeks Leadership With Cosentyx Showing No Radiographic Progression in Ankylosing Spondylitis at 4 Years

  The new data also confirm sustained improvement in signs and symptoms in almost 80 percent of patients, while Cosentyx delivers a favorable and consistent safety profile[1].

  November 6, 2017

   · 

  11 min read
• Deals

  Melinta Therapeutics Announces Successful Completion of Merger

  Melinta Therapeutics will commence trading on November 6, 2017 on the NASDAQ Global Market under the symbol “MLNT.”

  November 6, 2017

   · 

  8 min read